News from the Broad

The Broad Institute is committed to open sharing not only of its scientific data and tools, but also information and news about our progress towards achieving our mission. Below are just a few highlights from the Broad scientific community.
  • Philanthropists unite to accelerate global fight against tuberculosis with combined $20 million gift to Broad Institute

    June 22nd, 2015
    Philanthropists Seth Klarman, Bill Ackman lead other investors in New York and Boston with pioneering shared contribution
    Read Full Story
  • Sequencing Ebola's secrets

    June 18th, 2015
    Study reveals new insights into long-term outbreaks
    Read Full Story
  • Microbe L. lactis shows promise for ameliorating colitis

    June 17th, 2015

    In a recent paper published in the Proceedings of the National Academy of Sciences, researcher Wendy Garrett, of Harvard T.H. Chan School of Public Health and the Broad Institute, and colleagues identified a strain of bacteria with the potential to abate gut inflammation. They found that Lactococcus lactis, used in the manufacture of dairy products, naturally releases an antioxidant known as superoxide dismutase A (SodA) — but only if ruptured by a specific, bacteria-attacking enzyme. This chain of events helps to correct an imbalance of chemically reactive molecules within the body associated with gut inflammation. These findings suggest a possible treatment avenue for inflammatory bowel disease and other colon-related ailments.

  • Study demonstrates central role for NFkB in driving pathophysiology of MS

    June 15th, 2015

    A central regulator of inflammation, nuclear factor kappa B (NFkB), has been implicated as a driver of the autoimmune disease multiple sclerosis (MS). A team led by David Hafler, of the Broad Institute and Yale School of Medicine, demonstrated that MS-associated variants alter NFkB signaling pathways, leading to increased activation of NFkB and making cells more responsive to inflammatory stimuli. The work, featured in Science Translational Medicine, suggests that rapid genetic screening for variants associated with NFκB signaling may identify individuals amenable to therapeutics targeting this pathway.

  • Study examines role of lncRNAs in the brain

    June 10th, 2015

    To investigate the role of long noncoding RNAs (lncRNAs) in brain development, a team led by John Rinn and Paola Arlotta of the Broad Institute and Harvard Stem Cell Institute, and Harvard’s Giulio Tomassy, analyzed the expression of lncRNAs in the developing and adult brain using lncRNA-knockout mouse models. The resulting map of gene expression revealed surprising spatial temporal patterns where a lncRNA is expressed embryonically but not in adult brains and vice-versa. The researchers also found that about 25 percent of lncRNA deletions resulted in a “cis-like” regulatory role on local gene expression. The study, which appears in PNAS, suggests several avenues for future studies on these molecules in brain development and physiology.